Ischaemic Heart Disease (angina pectoris, acute coronary syndrome, myocardial infarction) Flashcards

1
Q

Definition

A

Characterised by decreased blood supply to the heart muscle resulting in chest pain (angina pectoris). May present as stable angina or acute coronary syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute coronary syndrome subdivisions

A

o Unstable angina - chest pain at rest due to ischaemia but without cardiac injury

o NSTEMI

o STEMI - ST elevation with transmural infarction

o NOTE: MI = cardiac muscle necrosis resulting from ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology

A

· COMMON

· Prevalence: > 2 %

· More common in males

· Annual incidence of MI in the UK ~ 5/1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aetiology

A

· Angina pectoris occurs when myocardial oxygen demand exceeds oxygen supply

· This is usually due to atherosclerosis

· Rarer causes of angina pectoris include coronary artery spasm (e.g. induced by cocaine), arteritis and emboli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Atherosclerosis pathophysiology

A

o Endothelial injury leads to migration of monocytes into the subendothelial space

o These monocytes differentiate into macrophages

o Macrophages accumulate LDL lipids and become foam cells

o These foam cells release growth factors that stimulate smooth muscle proliferation, production of collagen and proteoglycans

o This leads to the formation of an atherosclerotic plaque

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk factors

A
o Male
o Diabetes mellitus
o Family history
o Hypertension
o Hyperlipidaemia
o Smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Presenting symptoms (acute coronary syndrome)

A

o Acute-onset chest pain
o Central, heavy, tight, crushing pain
o Radiates to the arms, neck, jaw or epigastrium
o Occurs at rest
o More severe and frequent pain that previously occurring stable angina

o Associated symptoms:
· Breathlessness
· Sweating
· Nausea and vomiting
· SILENT INFARCTS occur in the elderly and diabetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presenting symptoms (stable angina)

A

o Chest pain brought on by exertion and relieved by rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Signs on physical examination (stable angina)

A

Check for signs of risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Signs on physical examination (acute coronary syndrome)

A
o There may be NO CLINICAL SIGNS
o Pale
o Sweating
o Restless
o Low-grade pyrexia
o Check both radial pulses to rule out aortic dissection
o Arrhythmias
o Disturbances of BP
o New heart murmurs
o Signs of complications (e.g. acute heart failure, cardiogenic shock)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations (bloods)

A
o FBC
o U&Es
o CRP
o Glucose
o Lipid profile
o Cardiac enzymes (troponins and CK-MB)
o Amylase (pancreatitis could mimic MI)
o TFTs
o AST and LDH (raised 24 and 48 hours post-MI, respectively)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Investigations (ECG)

A

Unstable Angina or NSTEMI:
· May show ST depression or T wave inversion

o STEMI:
· Hyperacute T waves
· ST elevation (> 1 mm in limb leads, > 2 mm in chest leads)
· New-onset LBBB
· Later changes:
§ T wave inversion
§ Pathological Q waves

o Relationship between ECG leads and the side of the heart
· Inferior: II, III, aVF
· Anterior: V1-V5/6
· Lateral: I, aVL, V5/6
· Posterior: Tall R wave and ST depression in V1-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Investigations (CXR)

A

Check for signs of heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Investigations (exercise ECG)

A

o Indications
· Patients with troponin-negative ACS or stable angina with a high pretest probability of coronary heart disease
· Pretest probability is based on characteristics of chest pain, cardiac risk factors, age and gender
· NOTE: digoxin is associated with giving a false-positive result

o Results:

· Positive Test: > 1 mm horizontal or downsloping ST depression measured at 80 ms after the end of the QRS complex

· Failed Test: failure to achieve at least 85% of the predicted maximal heart rate (220-age) and otherwise negative findings (no chest pain or ECG changes)
§ NOTE: beta-blockers reduce heart rate and so should be stopped before the test

· Resting ECG Abnormalities: e.g. pre-excitation syndrome, > 1 mm ST depression, LBBB or pacemaker ventricular rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Investigations (radionuclide myocardial perfusion imaging (rMPI))

A

o Uses Technetium-99m sestamibi or tetrofosmin

o Can be performed under stress or at rest

o Stress testing shows low uptake in ischaemic myocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigations (echocardiogram)

A

o Measures left ventricular ejection fraction

o Exercise or dobutamine stress echo may detect regional wall motion abnormalities

17
Q

Investigations (pharmacological stress testing)

A

o This is used in patients who are unable to exercise

o Pharmacological agents can be used to induce a tachycardia, such as:
· Dipyridamole
· Adenosine
· Dobutamine

o These agents are used in conjunction with various imaging modalities (e.g. rMPI, echocardiography) to detect ischaemic myocardium

o NOTE: Dypiridamole and adenosine are contraindicated in AV block and reactive airway disease

18
Q

Investigations (cardiac catheterisation/angiography)

A

Performed if ACS with positive troponin or if high risk on stress testing

19
Q

Investigations (coronary calcium scoring)

A

o Uses specialised CT scan

o May be useful in outpatients with atypical chest pain or in acute chest pain that isn’t clearly due to ischaemia

20
Q

Management plan (stable angina)

A

o Minimise cardiac risk factors (e.g. blood pressure, hyperlipidaemia, diabetes)
· All patients should receive aspirin 75 mg/day unless contraindicated

o Immediate symptom relief (e.g. GTN spray)

o Long-term management
· Beta-blockers
§ Contraindicated in:
· Acute heart failure
· Cardiogenic shock
· Bradycardia
· Heart block
· Asthma
· Calcium channel blockers
· Nitrates

o Percutaneous coronary intervention (PCI)
· Performed in patients with stable angina despite maximal tolerable medical therapy

o Coronary artery bypass graft (CABG)
· Occurs in more severe cases (e.g. three-vessel disease)

21
Q

Management plan (unstable angina/NSTEMI)

A

o Admit to coronary care unit
o Oxygen, IV access, monitor vital signs and serial ECG
o GTN
o Morphine
o Metoclopramide (to counteract the nausea caused by morphine)
o Aspirin (300 mg initially, followed by 75 mg indefinitely)
o Clopidogrel (300 mg initially, followed by 75 mg for at least 1 year if troponin positive or high risk)
o LMWH (e.g. enoxaparin)
o Beta-blocker (e.g. metoprolol)
o Glucose-insulin infusion if blood glucose > 11 mmol/L

o GlpIIb/IIIa inhibitors may also be considered (e.g. tirofiban) in patients:
· Undergoing PCI
· At high risk of further cardiac events
o If little improvement, consider urgent angiography with/without revascularisation

o NOTE: the acute management of ACS can be remembered using the mnemonic MONABASH
· Morphine
· Oxygen
· Nitrates
· Anticoagulants (aspirin + clopidogrel)
· Beta-blockers
· ACE inhibitors
· Statins
· Heparin
22
Q

Management plan (STEMI)

A

o Same as UAP/NSTEMI management except:

· Clopidogrel
§ 600 mg if patient is going to PCI
§ 300 mg if undergoing thrombolysis and < 75 yrs
§ 75 mg if undergoing thrombolysis and > 75 yrs
§ MAINTENANCE: 75 mg daily for at least 1 year

· If undergoing primary PCI:
§ IV heparin (plus GlpIIb/IIIa inhibitor)
§ Bivalirudin (antithrombin)

o Primary PCI
· Goal < 90 min if available

o Thrombolysis
· Uses fibrinolytics such as streptokinase and tissue plasminogen activator (e.g. alteplase)
· Only considered if within 12 hours of chest pain with ECG changes and not contraindicated
· Rescue PCI may be performed if continued chest pain or ST elevation after thrombolysis

o Secondary Prevention
· Dual antiplatelet therapy (aspirin + clopidogrel)
· Beta-blockers
· ACE inhibitors
· Statins
· Control risk factors

o Advice
· No driving for 1 month following MI

o CABG
· Considered in patients with left main stem or three-vessel disease

23
Q

Possible complications

A

· Increased risk of MI and other vascular disease (e.g. stroke, PVD)

· Cardiac injury from an MI can lead to heart failure and arrhythmias

24
Q

Early complications

A
o Death
o Cardiogenic shock
o Heart failure
o Ventricular arrythmias
o Heart block
o Pericarditis
o Myocardial rupture
o Thromboembolism
25
Q

Late complications

A
o Ventricular wall rupture
o Valvular regurgitation
o Ventricular aneurysms
o Tamponade
o Dressler's syndrome
o Thromboembolism
26
Q

Complications of MI

A

DARTH VADER

o Death
o Arrhythmias
o Rupture
o Tamponade
o Heart failure
o Valve disease
o Aneurysm
o Dressler's syndrome
o Embolism
o Reoccurrence regurgitation
27
Q

Prognosis

A

· TIMI score (0-7) can be used for risk stratification
o NOTE: TIMI = thrombolysis in myocardial infarction
o High scores are associated with high risk of cardiac events within 30 days of MI

· Killip Classification of acute MI can also be used:
o Class I: no evidence of heart failure
o Class II: mild to moderate heart failure
o Class III: over pulmonary oedema
o Class IV: cardiogenic shock